153 related articles for article (PubMed ID: 37717120)
1. A spectroscopic liquid biopsy for the earlier detection of multiple cancer types.
Cameron JM; Sala A; Antoniou G; Brennan PM; Butler HJ; Conn JJA; Connal S; Curran T; Hegarty MG; McHardy RG; Orringer D; Palmer DS; Smith BR; Baker MJ
Br J Cancer; 2023 Nov; 129(10):1658-1666. PubMed ID: 37717120
[TBL] [Abstract][Full Text] [Related]
2. Clinical validation of a spectroscopic liquid biopsy for earlier detection of brain cancer.
Cameron JM; Brennan PM; Antoniou G; Butler HJ; Christie L; Conn JJA; Curran T; Gray E; Hegarty MG; Jenkinson MD; Orringer D; Palmer DS; Sala A; Smith BR; Baker MJ
Neurooncol Adv; 2022; 4(1):vdac024. PubMed ID: 35316978
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Liquid Biopsy for Pancreatic Cancer Detection Using Infrared Spectroscopy.
Sala A; Cameron JM; Jenkins CA; Barr H; Christie L; Conn JJA; Evans TRJ; Harris DA; Palmer DS; Rinaldi C; Theakstone AG; Baker MJ
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804820
[TBL] [Abstract][Full Text] [Related]
6. Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer.
Huber M; Kepesidis KV; Voronina L; Fleischmann F; Fill E; Hermann J; Koch I; Milger-Kneidinger K; Kolben T; Schulz GB; Jokisch F; Behr J; Harbeck N; Reiser M; Stief C; Krausz F; Zigman M
Elife; 2021 Oct; 10():. PubMed ID: 34696827
[TBL] [Abstract][Full Text] [Related]
7. Breast-cancer detection using blood-based infrared molecular fingerprints.
Kepesidis KV; Bozic-Iven M; Huber M; Abdel-Aziz N; Kullab S; Abdelwarith A; Al Diab A; Al Ghamdi M; Hilal MA; Bahadoor MRK; Sharma A; Dabouz F; Arafah M; Azzeer AM; Krausz F; Alsaleh K; Zigman M; Nabholtz JM
BMC Cancer; 2021 Dec; 21(1):1287. PubMed ID: 34856945
[TBL] [Abstract][Full Text] [Related]
8. A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA.
Brikun I; Nusskern D; Decatus A; Harvey E; Li L; Freije D
Clin Epigenetics; 2018; 10():91. PubMed ID: 29988684
[TBL] [Abstract][Full Text] [Related]
9. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Rapid Spectroscopic Liquid Biopsy for the Universal Detection of Brain Tumours.
Theakstone AG; Brennan PM; Jenkinson MD; Mills SJ; Syed K; Rinaldi C; Xu Y; Goodacre R; Butler HJ; Palmer DS; Smith BR; Baker MJ
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359751
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
[TBL] [Abstract][Full Text] [Related]
13. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
14. Cell-Free Circulating Tumour DNA Blood Testing to Detect
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(5):1-176. PubMed ID: 32206157
[TBL] [Abstract][Full Text] [Related]
15. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
17. Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models.
Levegrün S; Jackson A; Zelefsky MJ; Venkatraman ES; Skwarchuk MW; Schlegel W; Fuks Z; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1245-60. PubMed ID: 10889378
[TBL] [Abstract][Full Text] [Related]
18. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
19. Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer.
Shen H; Jin Y; Zhao H; Wu M; Zhang K; Wei Z; Wang X; Wang Z; Li Y; Yang F; Wang J; Chen K
BMC Med; 2022 Dec; 20(1):480. PubMed ID: 36514063
[TBL] [Abstract][Full Text] [Related]
20. Predicting Positive Repeat Prostate Biopsy Outcomes: Comparison of Machine Learning Approaches to Identify Key Parameters and Optimal Algorithms.
Zhang X; Feng C; Bai X; Peng X; Guo Q; Chen L; Xue J
Arch Esp Urol; 2023 Sep; 76(7):494-503. PubMed ID: 37867334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
